SCHEMBL22284166

SCHEMBL22284166

COC(=O)/C=C/c1cc2c(-c3ccncc3)nn(C(c3ccccc3)(c3ccccc3)c3ccccc3)c2cc1[N+](=O)[O-]

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
POLB P06746 3/20 0.39
MAPT P10636 2/20 0.39
L3MBTL1 Q9Y468 2/20 0.39
GLA P06280 1/20 0.39
RECQL P46063 1/20 0.39
ATM Q13315 1/20 0.39
TDP1 Q9NUW8 1/20 0.39
ALDH1A1 P00352 5/20 0.37
CCNC P24863 1/20 0.36
CDK8 P49336 1/20 0.36
MEN1 O00255 3/20 0.35
KMT2A Q03164 3/20 0.35
GAA P10253 1/20 0.35
HPGD P15428 1/20 0.35
LMNA P02545 2/20 0.34
HTT P42858 1/20 0.34
RAB9A P51151 2/20 0.34
STAT3 P40763 1/20 0.34
NPC1 O15118 1/20 0.34
NFKB1 P19838 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20916968 1.00 POLB (0.39) POLBMAPTL3MBTL1GLARECQL
SCHEMBL20916815 0.90 MAPT (0.41) POLBMAPTL3MBTL1GLARECQL
SCHEMBL20916814 0.90 MAPT (0.41) POLBMAPTL3MBTL1GLARECQL
SCHEMBL30554306 0.90 MAPT (0.41) POLBMAPTL3MBTL1GLARECQL
SCHEMBL17567301 0.90 POLB (0.39) POLBMAPTL3MBTL1GLARECQL
SCHEMBL22284168 0.88 L3MBTL1 (0.36) POLBMAPTL3MBTL1GLARECQL
SCHEMBL22284169 0.88 L3MBTL1 (0.36) POLBMAPTL3MBTL1GLARECQL
SCHEMBL22497568 0.86 ALDH1A1 (0.37) POLBMAPTL3MBTL1GLARECQL
SCHEMBL22497569 0.86 ALDH1A1 (0.37) POLBMAPTL3MBTL1GLARECQL
SCHEMBL22284146 0.86 TDP1 (0.38) POLBTDP1ALDH1A1MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3699179-A1 PYRAZOLYL-CONTAINING TRICYCLIC DERIVATIVE, PREPARATION METHOD THEREFOR AND USE THEREOF Jiangsu Hansoh Pharmaceutical Group Co., Ltd. (CN) 2020-08-26 EP disclosed
US-20200247815-A1 PYRAZOLYL-CONTAINING TRICYCLIC DERIVATIVE, PREPARATION METHOD THEREFOR AND USE THEREOF SHANGHAI HANSOH BIOMEDICAL CO., LTD. (CN) 2020-08-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200247815-A1 PYRAZOLYL-CONTAINING TRICYCLIC DERIVATIVE, PREPARATION METHOD THEREFOR AND USE THEREOF MAPK1, MAPK11, MAPK14 POLB 3697/4885MAPT 3727/4885L3MBTL1 3754/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.